AZ Outlines COVID-19 Plans With Strong Q2 Update
UK Pharma Is Advancing Two MAbs Into COVID-19 Trials
AstraZeneca used its robust Q2 update to express hopes that Phase III data from of its COVID-19 vaccine candidate this year could provide it with a regulatory pathway. It is also entering a mAb combination into the clinic as a promising approach against COVID-19.
